Remove 2029 Remove Marketing Remove Vaccine
article thumbnail

Fewer New Drugs but Affordable Access for Existing Ones: The Big Elephant in the Room

Policy Prescription

Within the context of the global pandemic and a coming battle in Congress about the high cost of prescription drugs, Patients for Affordable Drugs founder David Mitchell tactfully presents the roadmap of Covid vaccine development to prevent people from buying into Big Pharma’s scare tactic. 3) were implemented.

Drugs 52
article thumbnail

Sanofi successfully priced an inaugural sustainability-linked bond indexed on access to medicines

The Pharma Data

650 million fixed rate notes, due April 2029, bearing interest at an annual rate of 1.250%. The transaction has been led by Morgan Stanley and Natixis CIB as Global Coordinators & Sustainability-Linked Structuring Advisors and, Barclays, MUFG and RBC Capital Markets, all as Joint Active Bookrunners.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is the largest CRO in the US?

Vial

By geographical region, the global CRO services market in 2023 was dominated by North America. Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog: Biosimilars

covered insulin product or vaccine). Each phase-in policy allows eligible manufacturers to build up in a stepwise manner to the 10% and 20% applicable discounts by 2029 and 2031, respectively. state pharmaceutical assistance programs). had Part D expenditures on or before August 16, 2022).